Charting the European Vaccine Landscape: Strategic Insights and National Priorities

CHALLENGE

A leading European strategy consultancy firm aimed to gain a comprehensive understanding of the European vaccine landscape, with a specific focus on new trends and strategic priorities. The firm sought to evaluate key market insights, emerging trends in the vaccine industry, and the strategic priorities of major European vaccine and chronic disease organizations. This understanding was essential for shaping their client’s strategies and informing their recommendations. To navigate the complexities of the European vaccine landscape, the client needed insights from high-level professionals with expertise in vaccine industry trends, organizational priorities, and strategic development. The goal was to connect with individuals who could offer a detailed perspective on the current and future directions of the vaccine industry in Europe.

BTHT APPROACH

The BTHT team organized and facilitated one-hour consultations with a curated selection of experts to provide a thorough understanding of the European vaccine landscape. Our approach was focused on identifying and engaging with influential members of key organizations and national vaccine industry groups, as well as top strategists from leading pharmaceutical companies. Our pipeline of experts comprised of:

• Members of the European Respiratory Society including executive committee members and advocacy council representatives.
• Members of the European Chronic Disease Alliance specifically from advocacy and policy groups or science groups with direct knowledge of organizational priorities.
• Former Leaders from National Vaccine Industry Groups such as LEEM (France), VFA (Germany), Farmindustria (Italy), ABPI (UK), and FarmaIndustria (Spain).
• Top Strategists from Pharmaceutical Companies like Emergex, Novo Nordisk, Bavarian Nordic, BioNTech, and Sinovac, focusing on heads of strategy or development.

OUTCOME

Through one-hour consultations with these distinguished experts, the European strategy consultancy firm acquired valuable insights into the evolving trends and strategic priorities in the European vaccine landscape. The discussions illuminated key market dynamics, organizational strategies, and emerging trends that are shaping the future of the vaccine industry. This comprehensive understanding empowered the firm to make informed strategic decisions and develop robust recommendations for their clients, positioning them effectively within the evolving European vaccine market.